Allurion Technologies 开发了一种用于减肥的可吞咽胃气球。 Allurion Technologies develops a swallowable gastric balloon for weight loss.

Allurion Technologies 开发了一种可吞咽式胃气球用于减肥，不需要手术、内窥镜检查或麻醉。 Allurion Technologies has developed a swallowable gastric balloon for weight loss that does not require surgery, endoscopy, or anesthesia. 与 FDA 批准的其他需要镇静和内窥镜检查才能放置或移除的球囊相比，该公司的球囊可能会在不久的将来改变减肥格局。 The company's balloon, in contrast to other FDA-approved balloons that need sedation and endoscopy for placement or removal, could change the weight loss landscape in the near future. Allurion 正在领导一项临床试验，以支持其球囊获得 FDA 批准。 Allurion is leading a clinical trial to support its balloon's FDA approval. 该公司预计将于 2024 年底得出结果，并计划随后向 FDA 提交申请。 The company anticipates the results by the end of 2024 and plans to submit its application to the FDA afterward.